InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HSO | Ann: Becoming a substantial holder | 26/03/19 | 1 | 179 | |||
|
|||||||
HSO | Ann: Change in substantial holding | 25/03/19 | 0 | 107 | |||
|
|||||||
HSO | Ann: Change in substantial holding | 25/03/19 | 0 | 71 | |||
|
|||||||
HSO | Ann: Ceasing to be a substantial holder | 25/03/19 | 0 | 102 | |||
|
|||||||
HSO | Ann: Change in substantial holding from NAB | 22/03/19 | 0 | 112 | |||
|
|||||||
HSO | Ann: Becoming a substantial holder | 22/03/19 | 0 | 112 | |||
|
|||||||
HSO | Ann: Change in substantial holding | 21/03/19 | 0 | 102 | |||
|
|||||||
HSO | News: HSO Healthscope Says Foreign Investment Review Board Approval Received For Brookfield... | 19/03/19 | 0 | 1.1K | |||
|
See All Discussions